REAP Financial Group’s Idexx Laboratories IDXX Stock Holding History

REAP Financial Group’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-3	Closed	-$1.67K	–	628
2023 Q4	$1.67K	Buy	+3	New	+$1.41K	﹤0.01%	560

Other funds holding IDXX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $13.6B AUM 7.6% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

REAP Financial Group's IDXX Position: Q1 2024 in Review

REAP Financial Group sold out of Idexx Laboratories (IDXX) in Q1 2024, closing a stake of 3 shares — an estimated $1.67K sold.

REAP Financial Group first reported a position in IDXX in Q4 2023 and held it in 1 quarter. The position peaked at $1.67K in Q4 2023. 1,149 funds tracked by Wall St. Rank hold IDXX as of Q1 2024.

REAP Financial Group reported no remaining Idexx Laboratories position as of Q1 2024 after selling out during the quarter.
REAP Financial Group sold 3 Idexx Laboratories shares in Q1 2024, an estimated $1.67K.
REAP Financial Group first reported a position in Idexx Laboratories in Q4 2023 and held it in 1 quarter.
REAP Financial Group's Idexx Laboratories position peaked at $1.67K in Q4 2023.
1,149 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2024.

Based on REAP Financial Group's 13F filing for Q1 2024, filed 27 Feb 2025.